Next-Generation Sequencing Informatics Market, By Products and Services (NGS Informatics Services and Data Analysis and Management Tool), By Application (Drug Discovery, Genetic Screening, Diseases Diagnosis, Precision Medicine, and Other Applications), By End- User (Hospitals and Clinics, Academics and Research Institutes, and Pharmaceuticals Companies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Next-generation sequencing informatics Market was valued at USD 11.8 Billion in 2024 and is projected to grow at a CAGR of 13.60% to reach USD 33.4 Billion by 2034.

The Next-generation sequencing informatics has fundamentally changed genomic research. NGS allows the scientist to sequence whole exome, genome, or transcriptome by practicing experiments that were previously not possible. There were some limitations for the traditional sequencing platforms. Next-generation sequencing is the revolutionized analysis of the transcriptomic. 

The rise in the application of NGS in the clinical diagnosis of various illnesses such as hematological disorders, cardiology, cancer, neurology, and others is the main propelling factor for the growth of the global market. Additionally, the advancement in the technology in the NGS informatics tools is another driving factor for the growth of the target market. For instance, in 2018, Illumina acquired Edico Genome, to accelerate the genomic data analysis and to enhance the NGS informatics tools. Moreover, increasing preference for the early diagnosis of diseases and rising demand for personalized medicine are the boosting factors for the growth of the global market. Furthermore, the increasing investments by the key players and the demand for NGS services are the fueling factors for the growth of the target market. However, the lack of a skilled technician for the NGS informatics services is the major restraining factor for the growth of the global market.  

Next-generation sequencing informatics market is segmented based on products and services, application, end-user, and region.

Based on products and services, the market is classified into NGS informatics services and data analysis and management tools. Based on the application, the target market is bifurcated into drug discovery, genetic screening, disease diagnosis, precision medicine, and other applications. Based on the end-user the global market is divided into hospitals and clinics, academics and research institutes, and pharmaceutical companies.

Based on the region the next-generation sequencing informatics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America region is expected to dominate the global next-generation sequencing information market because of the better healthcare infrastructure and increasing awareness regarding next-generation sequencing.

Detailed Segmentation:

Next-Generation Sequencing Informatics Market, By Products and Services:

• NGS Informatics Services
• Data Analysis and Management Tool

Next-Generation Sequencing Informatics Market, By Application:

• Drug Discovery
• Genetic Screening
• Diseases Diagnosis
• Precision Medicine
• Other Applications

Next-Generation Sequencing Informatics Market, By End-User:

• Hospitals and Clinics
• Academics and Research Institutes
• Pharmaceuticals Companies

Next-Generation Sequencing Informatics Market, By Region:

• North America
  • North America Next-Generation Sequencing Informatics Market, By Products and Services
  • North America Next-Generation Sequencing Informatics Market, By Application
  • North America Next-Generation Sequencing Informatics Market, By End-User
  • North America Next-Generation Sequencing Informatics Market, By Country
    • U.S.
    • Canada
• Europe
  • Europe Next-Generation Sequencing Informatics Market, By Products and Services
  • Europe Next-Generation Sequencing Informatics Market, By Application
  • Europe Next-Generation Sequencing Informatics Market, By End-User
  • Europe Next-Generation Sequencing Informatics Market, By Country
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Asia Pacific Next-Generation Sequencing Informatics Market, By Products and Services
  • Asia Pacific Next-Generation Sequencing Informatics Market, By Application
  • Asia Pacific Next-Generation Sequencing Informatics Market, By End-User
  • Asia Pacific Next-Generation Sequencing Informatics Market, By Country
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Latin America Next-Generation Sequencing Informatics Market, By Products and Services
  • Latin America Next-Generation Sequencing Informatics Market, By Application
  • Latin America Next-Generation Sequencing Informatics Market, By End-User
  • Latin America Next-Generation Sequencing Informatics Market, By Country
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East & Africa
  • Middle East & Africa Next-Generation Sequencing Informatics Market, By Products and Services
  • Middle East & Africa Next-Generation Sequencing Informatics Market, By Application
  • Middle East & Africa Next-Generation Sequencing Informatics Market, By End-User
  • Middle East & Africa Next-Generation Sequencing Informatics Market, By Country
    • GCC
    • Israel
    • South Africa
    • Rest of the Middle East & Africa

The key players operating the next-generation sequencing informatics market involve Agilent Technologies Inc., Amazon Web Services LLC, Dnanexus Inc., F. Hoffmann-La Roche Ltd., Intrexon Bioinformatics Germany GmbH (Genomatrix AG), Llumina Inc., Fabric Genomics Inc. (Omicia Inc.), Partek Incorporated, Qiagen NV, and Sapio Sciences. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of products to gain a competitive edge in the target market. For instance, in 2018, Llumina Inc. and Bristol-Myers Squibb declared a strategic collaboration to develop commercialized diagnostics for the Bristol- Myers Squibb’s oncology immunotherapies.

• Agilent Technologies Inc.
• Amazon Web Services LLC
• Dnanexus Inc.
• F. Hoffmann-La Roche Ltd
• Intrexon Bioinformatics Germany GmbH (Genomatrix AG)
• Llumina Inc.
• Fabric Genomics Inc. (Omicia Inc.)
• Partek Incorporated
• Qiagen NV
• Sapio Sciences